Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial
Raoul J. Koopmans, Maud A. Tjerkstra, Menno R. Germans, Mervyn D. I. Vergouwen et autres
BACKGROUND: The ULTRA trial demonstrated no improvement in clinical outcome at 6 months in patients with subarachnoid hemorrhage (SAH) when treated with ultra-early and short-term tranexamic acid (TXA). In this post hoc analysis, we evaluated the effect of TXA in females and …
nl, ch (code pays fourni par la source)
0 citations
Journal of Neurology